Literature DB >> 33517535

Developmental malformations in Huntington disease: neuropathologic evidence of focal neuronal migration defects in a subset of adult brains.

R A Hickman1, P L Faust2, M K Rosenblum3, K Marder4,5, M F Mehler6,7,8, J P Vonsattel2,5.   

Abstract

Neuropathologic hallmarks of Huntington Disease (HD) include the progressive neurodegeneration of the striatum and the presence of Huntingtin (HTT) aggregates that result from abnormal polyQ expansion of the HTT gene. Whether the pathogenic trinucleotide repeat expansion of the HTT gene causes neurodevelopmental abnormalities has garnered attention in both murine and human studies; however, documentation of discrete malformations in autopsy brains of HD individuals has yet to be described. We retrospectively searched the New York Brain Bank (discovery cohort) and an independent cohort (validation cohort) to determine whether developmental malformations are more frequently detected in HD versus non-HD brains and to document their neuropathologic features. One-hundred and thirty HD and 1600 non-HD whole brains were included in the discovery cohort and 720 HD and 1989 non-HD half brains were assessed in the validation cohort. Cases with developmental malformations were found at 6.4-8.2 times greater frequency in HD than in non-HD brains (discovery cohort: OR 8.68, 95% CI 3.48-21.63, P=4.8 × 10-5; validation cohort: OR 6.50, 95% CI 1.83-23.17, P=0.0050). Periventricular nodular heterotopias (PNH) were the most frequent malformations and contained HTT and p62 aggregates analogous to the cortex, whereas cortical malformations with immature neuronal populations did not harbor such inclusions. HD individuals with malformations had heterozygous HTT CAG expansions between 40 and 52 repeats, were more frequently women, and all were asymmetric and focal, aside from one midline hypothalamic hamartoma. Using two independent brain bank cohorts, this large neuropathologic series demonstrates an increased occurrence of developmental malformations in HD brains. Since pathogenic HTT gene expansion is associated with genomic instability, one possible explanation is that neuronal precursors are more susceptible to somatic mutation of genes involved in cortical migration. Our findings further support emerging evidence that pathogenic trinucleotide repeat expansions of the HTT gene may impact neurodevelopment.

Entities:  

Keywords:  Development; Hamartoma; Heterotopia; Huntingtin; Huntington disease; Malformation

Mesh:

Year:  2021        PMID: 33517535      PMCID: PMC7882590          DOI: 10.1007/s00401-021-02269-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  61 in total

1.  Morphology of the cerebral cortex in preclinical Huntington's disease.

Authors:  Peg Nopoulos; Vincent A Magnotta; Ania Mikos; Henry Paulson; Nancy C Andreasen; Jane S Paulsen
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

2.  Striatal and white matter predictors of estimated diagnosis for Huntington disease.

Authors:  Jane S Paulsen; Peggy C Nopoulos; Elizabeth Aylward; Christopher A Ross; Hans Johnson; Vincent A Magnotta; Andrew Juhl; Ronald K Pierson; James Mills; Douglas Langbehn; Martha Nance
Journal:  Brain Res Bull       Date:  2010-04-10       Impact factor: 4.077

3.  Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain.

Authors:  Peggy F Shelbourne; Christine Keller-McGandy; Wenya Linda Bi; Song-Ro Yoon; Louis Dubeau; Nicola J Veitch; Jean Paul Vonsattel; Nancy S Wexler; Norman Arnheim; Sarah J Augood
Journal:  Hum Mol Genet       Date:  2007-04-04       Impact factor: 6.150

4.  Distribution and immunoreactivity of cerebral micro-hamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2).

Authors:  O D Wiestler; K von Siebenthal; H P Schmitt; W Feiden; P Kleihues
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis.

Authors:  Taejeong Bae; Livia Tomasini; Jessica Mariani; Bo Zhou; Tanmoy Roychowdhury; Daniel Franjic; Mihovil Pletikos; Reenal Pattni; Bo-Juen Chen; Elisa Venturini; Bridget Riley-Gillis; Nenad Sestan; Alexander E Urban; Alexej Abyzov; Flora M Vaccarino
Journal:  Science       Date:  2017-12-07       Impact factor: 47.728

6.  Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Julie C Stout
Journal:  Biol Psychiatry       Date:  2007-05-03       Impact factor: 13.382

7.  Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.

Authors:  Laura Kennedy; Elizabeth Evans; Chiung-Mei Chen; Lyndsey Craven; Peter J Detloff; Margaret Ennis; Peggy F Shelbourne
Journal:  Hum Mol Genet       Date:  2003-10-21       Impact factor: 6.150

Review 8.  Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy. Clinical, EEG and neuroimaging features in 100 adult patients.

Authors:  A A Raymond; D R Fish; S M Sisodiya; N Alsanjari; J M Stevens; S D Shorvon
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

9.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.

Authors:  J Nasir; S B Floresco; J R O'Kusky; V M Diewert; J M Richman; J Zeisler; A Borowski; J D Marth; A G Phillips; M R Hayden
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

Review 10.  Cytoskeletal proteins in cortical development and disease: actin associated proteins in periventricular heterotopia.

Authors:  Gewei Lian; Volney L Sheen
Journal:  Front Cell Neurosci       Date:  2015-04-01       Impact factor: 5.505

View more
  8 in total

Review 1.  Neurogenetic disorders across the lifespan: from aberrant development to degeneration.

Authors:  Richard A Hickman; Sarah A O'Shea; Mark F Mehler; Wendy K Chung
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

2.  Amyotrophic lateral sclerosis is over-represented in two Huntington's disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion.

Authors:  Richard A Hickman; Ramita Dewan; Etty Cortes; Bryan J Traynor; Karen Marder; Jean-Paul Vonsattel
Journal:  Acta Neuropathol       Date:  2021-11-20       Impact factor: 17.088

3.  Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease.

Authors:  Hae Nim Lee; Seung Jae Hyeon; Heejung Kim; Kyoung Mi Sim; Yunha Kim; Jeongmin Ju; Junghee Lee; Yingxiao Wang; Hoon Ryu; Jihye Seong
Journal:  Acta Neuropathol       Date:  2022-07-20       Impact factor: 15.887

4.  Cortical Features in Child and Adolescent Carriers of Mutant Huntingtin (mHTT).

Authors:  Erin E Reasoner; Ellen van der Plas; Douglas R Langbehn; Amy L Conrad; Timothy R Koscik; Eric A Epping; Vincent A Magnotta; Peggy C Nopoulos
Journal:  J Huntingtons Dis       Date:  2022

Review 5.  Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Front Neurosci       Date:  2021-12-02       Impact factor: 4.677

6.  The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade.

Authors:  Richard A Hickman; Phyllis L Faust; Karen Marder; Ai Yamamoto; Jean-Paul Vonsattel
Journal:  Acta Neuropathol Commun       Date:  2022-04-19       Impact factor: 7.578

Review 7.  Flying under the radar: CDH2 (N-cadherin), an important hub molecule in neurodevelopmental and neurodegenerative diseases.

Authors:  Zsófia I László; Zsolt Lele
Journal:  Front Neurosci       Date:  2022-09-23       Impact factor: 5.152

8.  Neurodevelopment affected by HD mutation.

Authors:  Ian Fyfe
Journal:  Nat Rev Neurol       Date:  2021-03       Impact factor: 42.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.